US annual deaths due to alcohol1
US annual ER visits due to alcohol2
US annual economic cost due to drinking3
The human beings. The victims. Their families.
The doctors and nurses. The strain on the healthcare system.
Violent Crime. Incarceration. Domestic Abuse.
The world has come to accept this.
We cannot.
We are working to solve this problem.
After more than a decade of R&D, GOA26 has advanced through sophisticated protein engineering, formulation and manufacturing and successful IND-enabling testing
in porcine models.
These scientific, regulatory and manufacturing achievements are progressing GOA26 toward IND filing
and clinical studies and have brought together a world-class multidisciplinary team spanning drug development, emergency medicine, trauma surgery and commercialization.
GOA26 is protected by a growing global intellectual property portfolio encompassing more than 30 patent filings worldwide.
¹ Esser MB et al. MMWR 2024;73(8):154–161; National Institute on Alcohol Abuse and Alcoholism (NIAAA).
² ClearView GOA-26 Opportunity Assessment, June 2026; GOA Therapeutics, data on file (2026).
³ Sacks JJ et al. American Journal of Preventive Medicine. 2015;49(5):e73–e79. Based on 2010 data
